Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis

Conclusion: Mortality at 12 weeks in participants with RR-TB was high compared to participants with RS-TB. Delays in the initiation of appropriate treatment and poorer regimen efficacy are proposed as contributors to higher mortality in hospitalised patients with HIV and RR-TB.
Source: Southern African Journal of HIV Medicine - Category: African Health Authors: Source Type: research